The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients

Renal Failure

Volumn 30, Issue 4, 2008, Pages 391-400

  Tian, Jun Ping ^a   Wang, Tao ^b   Wang, Hong ^c   Cheng, Li Tao ^b   Tian, Xin Kui ^b   Lindholm, Bengt ^d   Axelsson, Jonas ^d   Du, Feng He ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c Shanxi Fenyang Hospital   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Hemodialysis; Hemodynamics; Left ventricular hypertrophy; Peritoneal dialysis; Volume

Indexed keywords

ARTICLE; BIOENERGY; BLOOD PRESSURE MEASUREMENT; BLOOD VOLUME; BODY FLUID; CHINESE; COMORBIDITY; COMPARATIVE STUDY; DEMOGRAPHY; ECHOCARDIOGRAPHY; EXTRACELLULAR SPACE; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEMODIALYSIS PATIENT; HEMODYNAMICS; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CAUSALITY; CHINA; COHORT STUDIES; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PREVALENCE; PROBABILITY; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 45749128749     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220801964178     Document Type: Article

References (37)

1. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of Left Ventricular Hypertrophy on Survival in End-Stage Renal Disease. Kidney Int. 1989;36:286-290.
2. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RS, Junor BJ, McMillan MA, Briggs JD. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant. 1998;13:1499-1505.
3. Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ. Serial echocardiographic changes in patients on hemodialysis: An evaluation of guideline implementation. J Nephrol. 2006;19:783-793.
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186-192.
5. Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol. 2003;93:94-101.
6. Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM. Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension. 1985;7:714-721.
7. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation. 1994;90:2786-2796.
8. Lameire N. Volume control in peritoneal dialysis patients: Role of new dialysis solutions. Blood Purif. 2004;22:44-54.
9. London GM, Guerin AP, Marchais SJ. Pathophysiology of left ventricular hypertrophy in dialysis patients. Blood Purif. 1994;12:277-283.
10. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant. 2001;16:1459-1464.
11. Hemmelgarn BR, Chou S, Wiebe N, Culleton BF, Manns BJ, Klarenbach S, Khan NA, Gourishankar S, Yeates KE, Gill JS, Tonelli M. Differences in use of peritoneal dialysis and survival among east Asian, Indo Asian, and white ESRD patients in Canada. Am J Kidney Dis. 2006;48:964-971.
12. Wang T, Tziviskou E, Chu M, Bargman J, Jassal V, Vas S, Oreopoulos DG. Differences in survival on peritoneal dialysis between oriental Asians and Caucasians: One center's experience. Int Urol Nephrol. 2003;35:267-274.
13. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Wang AY, Lui SF, Li PK. Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2001;12:355-360.
14. Jabary NS, Herrero AM, Gonzalez JA. The use of antihypertensive therapy in Spain (1986-1994). Am J Hypertens. 2000;13:607-610.
15. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol. 1993;4:1205-1213.
16. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33:27-39.
17. Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis. 2005;45:891-902.
18. Sahn DJ, Demaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
20. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J III, Feinleib M, Castelli WP. The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation. 1987;75:I26-I33.
21. Huntsman LL, Stewart DK, Barnes SR, Franklin SB, Colocousis JS, Hessel EA. Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation. 1983;67:593-602.
22. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. 2001;12:2759-2767.
23. Gunal AI, Ilkay E, Kirciman E, Karaca I, Dogukan A, Celiker H. Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: A cross-sectional study. Perit Dial Int. 2003;23:563-567.
24. Canziani ME, Cendoroglo NM, Saragoca MA, Cassiolato JL, Ramos OL, Ajzen H, Draibe SA. Hemodialysis versus continuous ambulatory peritoneal dialysis: Effects on the heart. Artif Organs. 1995;19:241-244.
25. Blumberg A, Nelp WB, Hegstrom RM, Scribner BH. Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction. Lancet. 1967;2:69-73.
26. Huting J, Alpert MA. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation. Clin Cardiol. 1992;15:190-196.
27. Unger P, Velez-Roa S, Wissing KM, Hoang AD, van de Borne P. Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: A long-term follow-up. Am J Transplant. 2004;4:2038-2044.
28. Unger P, Wissing KM, de Pauw L, Neubauer J, van de Borne P. Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation. 2002;74:73-79.
29. Pei YP, Greenwood CM, Chery AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int. 2000;58:1293-1299.
30. Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LY, Daugirdas JT. Survival advantage in Asian American end-stage renal disease patients. Kidney Int. 1999;55:2515-2523.
31. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, Ng FS, Cheng IK. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64:649-656.
32. Chung SH, Heimburger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: A comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005;20:1207-1213.
33. Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol. 2000;20:396-401.
34. Silberberg JS, Rahal DP, Patton DR, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol. 1989;64:222-224.
35. Wizemann V, Schafer R, Kramer W. Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy. Nephron. 1993;64:202-206.
36. Fagugli RM, Pasini P, Quintaliani G, Pasticci F, Ciao G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F, Valente F, Buoncristiani U. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant. 2003;18:2332-2338.
37. Peixoto AJ, Santos SF, Mendes RB, Crowley ST, Maldonado R, Orias M, Mansoor GA, White WB. Reproducibility Of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis. 2000;36:983-990.